Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H43NO |
| Molecular Weight | 337.5829 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCC\C=C/CCCCCCCCCCCC(N)=O
InChI
InChIKey=UAUDZVJPLUQNMU-KTKRTIGZSA-N
InChI=1S/C22H43NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h9-10H,2-8,11-21H2,1H3,(H2,23,24)/b10-9-
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/28082151
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28082151
Erucamide is a fatty acid amide, which is similar to the classical endocannabinoid analog oleoylethanolamide. It was discovered in mice, that erucamide may regulate the central nervous system and may have the potential to antagonize depression and anxiety and these effects of the compound may be related to the regulation of the hypothalamus-pituitary-adrenal axis (HPA).
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28082151
Curator's Comment: may regulate the central nervous system in mice, human data not available
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28082151
in mice: 5, 10, 20mg/kg,
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB185188
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
112-84-5
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
5365371
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
1545045
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
DTXSID4026929
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
0V89VY25BN
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
142245
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
5577
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
C049508
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
100000170967
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY | |||
|
204-009-2
Created by
admin on Mon Mar 31 18:42:49 GMT 2025 , Edited by admin on Mon Mar 31 18:42:49 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD